Crowd gathering at the Westin St. Francis for JPM in 2019 (Endpoints News)
December 15, 2021 10:37 AM EST
Pharma

#JPM22 goes vir­tu­al, cav­ing to pres­sure af­ter a wave of big drug­mak­ers pull out due to Omi­cron fears

Kyle Blankenship

Well, see you in Jan­u­ary 2023.

In a sur­prise about-face, #JPM22 will now be ful­ly vir­tu­al af­ter or­ga­niz­ers of the pop­u­lar biotech con­fer­ence de­cid­ed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times